Cyclerion Therapeutics, Inc. Liquidation Value
CYCN
Other
Cash & Equivalents
$3.24M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $3.24M
Total Obligations: -$900,000
$2.34M
Per share: $0.61
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $3.24M
AR: $1.00M
Total Obligations: -$900,000
$3.34M
Per share: $0.87
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $3.24M
AR: $1.00M
Inventory: $0
Total Obligations: -$900,000
$3.34M
Per share: $0.87
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $2.34M | $0.61 |
| Liquid Liquidation Value | $3.34M | $0.87 |
| Operating Liquidation Value | $3.34M | $0.87 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $3.24M |
| Accounts Receivable | $1.00M |
| Inventory | N/A |
| Current Liabilities | $900,000 |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 3.8M |
Explore all 182 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $3.24M | $1.00M | N/A | $508,000 | $900,000 | N/A | N/A | N/A |
| 2025-09-30 | $4.57M | $100,000 | N/A | $480,000 | $877,000 | N/A | N/A | N/A |
| 2025-06-30 | $3.01M | $525,000 | N/A | $462,000 | $800,000 | N/A | N/A | N/A |
| 2025-03-31 | $3.64M | $581,000 | N/A | $483,000 | $1.07M | N/A | N/A | N/A |
| 2024-12-31 | $3.23M | $556,000 | N/A | $390,000 | $725,000 | N/A | N/A | N/A |
| 2024-09-30 | $2.87M | $44,000 | N/A | $304,000 | $700,000 | N/A | N/A | N/A |
| 2024-06-30 | $4.59M | N/A | N/A | $651,000 | $1.28M | N/A | N/A | N/A |
| 2024-03-31 | $5.70M | N/A | N/A | $741,000 | $1.44M | N/A | N/A | N/A |
▼ Community Notes